Under COVID of the night

od Sekeres, Mikkael A.
Wydane w Blood (2020)

The Revolution of Myelodysplastic Syndromes

od Sekeres, Mikkael A., Bejanyan, Nelli
Wydane 2011

On the Edge of Life, I: Assessment of, Reaction to, and Management of the Terminally Ill Recorded in an Intensive Care Unit Journal

od Sekeres, Mikkael A., Stern, Theodore A.
Wydane 2002

On the Edge of Life, II: House Officer Struggles Recorded in an Intensive Care Unit Journal

od Sekeres, Mikkael A., Stern, Theodore A.
Wydane 2002

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin

od Duong, Hien K, Sekeres, Mikkael A
Wydane 2009

Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment

od Sekeres, Mikkael A., Steensma, David P.
Wydane 2009

Lowering the boom on lower-risk myelodysplastic syndromes

od Sekeres, Mikkael A., Patel, Bhumika J.
Wydane w Hematology Am Soc Hematol Educ Program (2019)

The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure

od DeZern, Amy E., Sekeres, Mikkael A.
Wydane 2014

Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?

od Nazha, Aziz, Sekeres, Mikkael A., Gore, Steven D., Zeidan, Amer M.
Wydane w Oncologist (2015)

The need for additional genetic markers for MDS stratification: what does the future hold for prognostication?

od Otrock, Zaher K., Tiu, Ramon V., Maciejewski, Jaroslaw P., Sekeres, Mikkael A.
Wydane w Expert Rev Hematol (2013)

Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years

od Borate, Uma, Norris, Brianna A., Statler, Abby, Fu, Rongwei, Bucy, Taylor, Sekeres, Mikkael A.
Wydane w Blood Adv (2019)

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

od Gabrilove, Janice, Paquette, Ronald, Lyons, Roger M, Mushtaq, Chaudhry, Sekeres, Mikkael A, Tomita, Dianne, Dreiling, Lyndah
Wydane 2008

Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms

od Przychodzen, Bartlomiej, Jerez, Andres, Guinta, Kathryn, Sekeres, Mikkael A., Padgett, Richard, Maciejewski, Jaroslaw P., Makishima, Hideki
Wydane 2013

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

od Gondek, Lukasz P., Tiu, Ramon, O'Keefe, Christine L., Sekeres, Mikkael A., Theil, Karl S., Maciejewski, Jaroslaw P.
Wydane 2008

Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys

od Sekeres, Mikkael A., Schoonen, W. Marieke, Kantarjian, Hagop, List, Alan, Fryzek, Jon, Paquette, Ronald, Maciejewski, Jaroslaw P.
Wydane 2008

Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies

od Othus, Megan, Sekeres, Mikkael A., Nand, Sucha, Garcia-Manero, Guillermo, Appelbaum, Frederick R., Erba, Harry P., Estey, Eli
Wydane w Leukemia (2018)

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

od Szpurka, Hadrian, Tiu, Ramon, Murugesan, Gurunathan, Aboudola, Samer, Hsi, Eric D., Theil, Karl S., Sekeres, Mikkael A., Maciejewski, Jaroslaw P.
Wydane 2006

Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes

od Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Giagounidis, Aristotle A.N., Wride, Kenton, Knight, Robert, Raza, Azra, List, Alan F.
Wydane 2008

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

od Steensma, David P., Bejar, Rafael, Jaiswal, Siddhartha, Lindsley, R. Coleman, Sekeres, Mikkael A., Hasserjian, Robert P., Ebert, Benjamin L.
Wydane w Blood (2015)

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

od Sekeres, Mikkael A., Elson, Paul, Kalaycio, Matt E., Advani, Anjali S., Copelan, Edward A., Faderl, Stefan, Kantarjian, Hagop M., Estey, Elihu
Wydane 2009